BHVNBiohaven Ltd.
$12.09-16% 1Y
$12.09
$7.7952 weeks$18.11
BHVN as reported
- Net income
- −$587M
Net income · −23% year on year · trailing twelve months to Q2 2026
- Free cash flow
- −$512M
Free cash flow · −21% year on year · trailing twelve months to Q2 2026
- EPS
- −$4.55
EPS · −40% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$587M | −23% | Q2 2026 |
| EPS | −$4.55 | −40% | Q2 2026 |
| ROE | −544% | n/a | Q2 2026 |
| ROA | −163% | n/a | Q2 2026 |
| Free cash flow | −$512M | −21% | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Biohaven Ltd. (BHVN) · Net incomeNet incomeBiohaven Ltd. (BHVN)
On our screens:Most shorted stocks